News Archive
Resources Section
Contact
UK Office
Only Medics
Second Floor
7 - 11 Station Road
Reading, Berkshire
RG1 1LG, UK
Tel -
+44(0)1189 522799
Email -
info@onlymedics.com
EU Office
Only Medics
Quantum House
22 - 24 Red Lion Court
Fleet Street, London
EC4A 3EB, UK
Tel -
+44(0)2078 221719
Share &
Connect
Keep connected & join the Only Medics Network here.
Specialist Sectors
-
GPs to ‘prescribe’ apps for patients
Family doctors in England could soon be asked to ‘prescribe’ apps to patients to help them manage their medical conditions. The Department of Health has said it wants GPs to be able to prescribe d...
-
EMA to open up drug evaluation process
The European Medicines Agency will publish ongoing drug evaluations in an effort to make its processes more transparent. The Agency currently only publishes its conclusions on drug evaluations, but th...
-
FDA moves to ease cancer drug shortages
FDA moves to ease cancer drug shortages...
-
Alex Gorsky to succeed William Weldon as J&J CEO
Alex Gorsky to succeed William Weldon as J&J CEO...
-
CCGs already helping patients, says Lansley
The government has set out a number of ways in which its controversial health reforms are already benefiting patients. The reorganisation of GP practices into clinical commissioning groups (CCGs), giv...
-
The pharma summit 2012 – finding new directions
Rebecca Aris gives an overview of the topics discussed at the recent Economist conference ‘The pharma summit 2012 – finding new directions’. R&D costs are increasing facing pharma with, ac...
-
Alex Gorsky named new chief executive of J&J
Johnson & Johnson has named Alex Gorsky as its new chief executive, effective from 26 April. Gorsky was also nominated for election to the board of directors and will replace the long serving Bill...
-
Takeda’s ulcerative colitis drug gets Phase III boost
Takeda’s ulcerative colitis drug vedolizumab has succeeded in a late-stage trial. The Phase III trial studied vedolizumab in 895 patients with moderately to severely active ulcerative colitis ...
-
Publicis buys Chinese med comms firm
Publicis has acquired Chinese healthcare communications firm U-Link Business Solutions (UBS), adding to its portfolio in Asia. UBS will become part of Publicis Healthcare Communications Group (PHCG) a...
-
GSK takes up option to develop two Galapagos compounds
GSK takes up option to develop two Galapagos compounds...
-
Novartis bags rights to Enanta HCV drug in $440 million deal
Novartis bags rights to Enanta HCV drug in $440 million deal...
-
EMA to publish ongoing drug evaluation info from March 1
EMA to publish ongoing drug evaluation info from March 1...
-
Caprelsa approved in Europe for thyroid cancer
The European Commission has approved AstraZeneca’s thyroid cancer pill Caprelsa. Caprelsa (vandetanib) is now available in Europe for the treatment of aggressive and symptomatic medullary thyroid ca...
-
Zytiga approved in Wales - for now
Janssen’s cancer treatment Zytiga has been approved in Wales, in contrast to its rejection by NICE. The All Wales Medicines Strategy Group (AWMSG) says that Zytiga (abiraterone acetate) can be used ...
-
Working Life: Georg Toufar, director, Mundipharma
Georg Toufar is director of European marketing and sales and member of the executive committee at Mundipharma International Limited (MINT). In this role he has responsibility for the company’s...
-
Green pharmaceutical manufacturing
Johan Geerinck shares with us the steps that Johnson & Johnson are taking towards sustainable processing and how the industry as a whole can become greener. The demand for implementation of sust...
-
Sweden's Karo Bio cuts a quarter of staff
Sweden's Karo Bio cuts a quarter of staff...
-
Bayer eye drug succeeds in long-term study
Bayer’s eye drug aflibercept has succeeded in a long-term study in patients with a common eye condition. The Phase III trial studied patients with macular oedema due to central retinal vein oc...
-
Europe approves AZ's Caprelsa for advanced MTC
Europe approves AZ's Caprelsa for advanced MTC...
-
MHRA suspends Teva licence for levothyroxine generic
The UK medicine regulatory authority has suspended the licence for a levothyroxine product sold by Teva on the grounds that it may not be interchangeable for other products used to treat hypothyroidis...
News
Testimonials
- Right from the very start, I have been p...
- Exceptional service demands recognition....
- Thank you for all your help and support ...
- I want to thank you for your help and gu...
- Thank you for all your help and support ...
- Thanks so much for helping me to find a ...
- As of today I have been in-post for 3 mo...
- Thanks so much for your help and negotia...
- We had been trying to recruit for two me...
- I just wanted to put in writing my grati...